Home > Insider Trading > Filing (0001209191-13-022758)

Filing Details

Accession Number:: 0001209191-13-022758
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-26 16:02:28
Reporting Period:: 2013-04-24

Filing Date:: 2013-04-26
Accepted Time:: 2013-04-26 16:02:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100962	Endo Health Solutions Inc.	ENDP	Pharmaceutical Preparations (2834)	134022871

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1328288	P. Ivan Gergel	C/O Endo Health Solutions Inc. 1400 Atwater Drive Malvern PA 19355	Evp, R&D And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value, $.01 Per Share	Acquisiton	2013-04-24	12,500	$25.02	45,535	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2013-04-24	12,500	$36.48	33,035	No	4	S	Direct
Common Stock, Par Value, $.01 Per Share	Acquisiton	2013-04-24	61,206	$19.93	94,241	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2013-04-24	61,206	$36.46	33,035	No	4	S	Direct
Common Stock, Par Value, $.01 Per Share	Acquisiton	2013-04-24	31,484	$20.61	64,519	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2013-04-24	31,484	$36.48	33,035	No	4	S	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2013-04-24	33,035	$36.41	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2013-04-24	12,500	$0.00	12,500	$25.02
Common Stock	2007 Stock Incentive Plan Stock Options (NQ)	Disposition	2013-04-24	61,206	$0.00	61,206	$19.93
Common Stock	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2013-04-24	31,484	$0.00	31,484	$20.61

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-04-29	No	4	M	Direct
0	2019-02-26	No	4	M	Direct
15,742	2020-02-19	No	4	M	Direct

Footnotes

On March 5, 2013, Dr. Gergel placed 105,190 of the shares underlying his stock options and 33,035 shares of common stock, which he had obtained upon vesting of certain restricted stock units and performance share units, into a 10b5-1 pre-set selling program (the "Gergel Pre-Set Selling Program"). The Gergel Pre-Set Selling Program's initial termination date was the earlier of March 5, 2014 or the date all shares under the program were sold. The options exercised and the shares sold here were sold pursuant to the Gergel Pre-Set Selling Program, which leaves no remaining shares (underlying options or otherwise) in the current Gergel Pre-Set Selling Program.
This represents the average price at which Dr. Gergel's common shares were sold on on April 24, 2013 with respect to each reported transaction.
Dr. Gergel's stock options that were granted under the 2004 Stock Incentive Plan on April 29, 2008 were generally exercisable 25% per year on each of April 29, 2009, April 29, 2010, April 29, 2011 and April 29, 2012. The 12,500 stock options that were exercised now are those that became exercisable on April 29, 2012.
These securities were granted to Dr. Gergel in consideration of his services as the Executive Vice President, Research & Development of Endo Health Solutions Inc.
Dr. Gergel's stock options that were granted under the 2007 Stock Incentive Plan on February 26, 2009 were generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012 and February 26, 2013. The 61,206 stock options that were exercised now are those that became exercisable on February 26, 2012 and February 26, 2013.
Dr. Gergel's stock options that were granted under the 2004 Stock Incentive Plan on February 19, 2010 are generally exercisable 25% per year on each of February 19, 2011, February 19, 2012, February 19, 2013 and February 19, 2014. The 31,484 stock options that were exercised now are those that became exercisable on February 19, 2012 and February 19, 2013.